S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Osiris Therapeutics, Inc. (2013/10/23)|
|Osiris Therapeutics Announces Leadership Transition (2013/12/2)|
|Osiris Announces Agreement for Culture-Expanded MSCs Including Prochymal Worth Up To $100 Million Plus Royalties (2013/10/10)|
|Osiris Legal Team Responds to False and Misleading Story by TheStreet.com (2013/10/21)|
|Osiris Reports 3rd Quarter 2013 Results: Revenue Up 220%, Strong Balance Sheet, Profitable and Now Cash Flow Positive from Continuing Operations (2013/11/1)|
|Osiris Corrects Certain Inaccuracies in Media Reports (2013/10/24)|
|Osiris to Present Grafix® Clinical and Scientific Data at 10th Annual Desert Foot High Risk Diabetic Foot Conference (2013/11/19)|
|Osiris Therapeutics Announces Second Quarter 2013 Financial Results ()|
|Osiris and FDA Reach Agreement on Regulatory Pathway for Biosurgery Products (2013/10/21)|
|Osiris Therapeutics Schedules Conference Call to Provide Update on its Grafix® Diabetic Foot Ulcer Trial ()|
Click above to view more mutual fund data and stats for osrs - Osiris Corporation.